NMDA receptor subunits: Diversity, development and disease

Current Opinion in Neurobiology

Volumn 11, Issue 3, 2001, Pages 327-335

  Cull Candy, S ^a   Brickley, S ^a   Farrant, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 4 [3 [4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 HYDROXYPROPOXY]BENZAMIDE; AMANTADINE; APTIGANEL; CONANTOKIN G; DIZOCILPINE; ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID); FELBAMATE; GAVESTINEL; GLUTAMIC ACID; HALOPERIDOL; IFENPRODIL; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PHENYLETHANOLAMINE DERIVATIVE; PROTON; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; SPERMINE; TRAXOPRODIL; UNCLASSIFIED DRUG; ZINC ION;

CENTRAL NERVOUS SYSTEM; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; REVIEW; SYNAPSE;

EID: 0035369112     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(00)00215-4     Document Type: Review

References (83)

1. The glutamate receptor ion channels
2. Molecular mechanisms of glutamate receptor clustering at excitatory synapses
3. Structure of ionotropic glutamate receptors
4. LTP and activity-dependent synaptogenesis: The more alike they are, the more different they become
5. Molecular cloning and characterization of the rat NMDA receptor
6. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing
7. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
8. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
9. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats
10. Assembly with NR1 subunit is required for surface expression of NR3A-containing NMDA receptors
11. Single-channel activations and concentration jumps: Comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors
12. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors
13. Activation of single AMPA- and NMDA-type glutamate-receptor channels
14. Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit
15. Molecular determinants of NMDA receptor function in GABAergic neurones of rat forebrain
16. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1
17. Immunohistochemical localization of N-methyl-D-aspartate receptor NR1, NR2A, NR2B and NR2C/D subunits in the adult mammalian cerebellum
18. Functional correlation of NMDA receptor epsilon subunits expression with the properties of single-channel and synaptic currents in the developing cerebellum
19. Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene
20. Synapse-selective impairment of NMDA receptor functions in mice lacking NMDA receptor ε1 or ε2 subunit
21. NMDA-receptor channel diversity in the developing cerebellum
22. 2+ in rat central neurones
23. Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons
24. Identification of subunits contributing to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum
25. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex
26. Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses
27. Slow deactivation kinetics of NMDA receptors containing NR1 and NR2D subunits in rat cerebellar Purkinje cells
28. Kinetics of NMDA channel opening
29. Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors
30. Single-channel analysis of an NMDA receptor possessing a mutation in the region of the glutamate binding site
31. Evidence for a tetrameric structure of recombinant NMDA receptors
32. Mutational analysis of the glycine-binding site of the NMDA receptor: Structural similarity with bacterial amino acid-binding proteins
33. Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the ε2 (NR2B) subunit
34. Single-channel currents from recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes
35. Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes
36. 2+ influx and reversal potentials in recombinant N-methyl-D-aspartate receptor channels
37. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines
38. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit
39. High-affinity zinc inhibition of NMDA NR1-NR2A receptors
40. Exon 5 and spermine regulate deactivation of NMDA receptor subtypes
41. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA
42. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule
43. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition
44. Ligands for glutamate receptors: Design and therapeutic prospects
45. Subunit- and site-specific pharmacology of the NMDA receptor channel
46. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors
47. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol
48. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-D-aspartate responses
49. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors
50. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction
51. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro
52. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord
53. Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo
54. Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret
55. Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells
56. Development of intrinsic and synaptic properties in a forebrain nucleus essential to avian song learning
57. Androgens modulate NMDA receptor-mediated EPSCs in the zebra finch song system
58. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons
59. NMDA receptor diversity in the cerebellum: Identification of subunits contributing to functional receptors
60. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
61. Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: Direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex
62. Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors
63. Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns
64. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits
65. The changing landscape of ischaemic brain injury mechanisms
66. Current and novel approaches to the drug treatment of schizophrenia
67. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
68. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor ε1 subunit
69. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
70. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. GAIN International Investigators
71. Attenuation of focal cerebral infarct in mice lacking NMDA receptor subunit NR2C
72. Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-D-aspartate receptors
73. Genetic enhancement of learning and memory in mice
74. Characterization in cultured cerebellar granule cells and in the developing rat brain of mRNA variants for the NMDA receptor 2C subunit
75. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist
76. An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors
77. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: Insights into the mechanism of action
78. Visual experience and deprivation bidirectionally modify the composition and function of NMDA receptors in visual cortex
79. NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses
80. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression
81. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signalling
82. Potentiation of NMDA receptor function by the serine protease thrombin
83. Serine proteases and brain damage - Is there a link?